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Fibrochondrogenesis Results from Mutations
in the COL11A1 Type XI Collagen Gene
Stuart W. Tompson,1 Carlos A. Bacino,2 Nicole P. Safina,3 Michael B. Bober,4 Virginia K. Proud,3
Tara Funari,1 Michael F. Wangler,2 Lisette Nevarez,1 Leena Ala-Kokko,5 William R. Wilcox,1,9
David R. Eyre,6 Deborah Krakow,1,7,8 and Daniel H. Cohn1,7,9,*
Fibrochondrogenesis is a severe, autosomal-recessive, short-limbed skeletal dysplasia. In a single case of fibrochondrogenesis, whole-
genome SNP genotyping identified unknown ancestral consanguinity by detecting three autozygous regions. Because of the predomi-
nantly skeletal nature of the phenotype, the 389 genes localized to the autozygous intervals were prioritized for mutation analysis by
correlation of their expression with known cartilage-selective genes via the UCLA Gene Expression Tool, UGET. The gene encoding
the a1 chain of type XI collagen (COL11A1) was the only cartilage-selective gene among the three candidate intervals. Sequence analysis
of COL11A1 in two genetically independent fibrochondrogenesis cases demonstrated that each was a compound heterozygote for a
loss-of-functionmutation on one allele and amutation predicting substitution for a conserved triple-helical glycine residue on the other.
The parents who were carriers of missense mutations hadmyopia. Early-onset hearing loss was noted in both parents who carried a loss-
of-function allele, suggestingCOL11A1 as a locus formild, dominantly inherited hearing loss. These findings identifyCOL11A1 as a locus
for fibrochondrogenesis and indicate that there might be phenotypic manifestations among carriers.Fibrochondrogenesis (MIM 228520) is a severe, autosomal-
recessive, short-limbed skeletal dysplasia first described in
1978.1 The disease is clinically characterized by a flat mid-
face with a small nose and anteverted nares, significant
shortening of all limb segments but relatively normal
hands and feet, and a small bell-shaped thorax with a
protuberant abdomen.2–8 Radiographically, the long bones
are short and have broad metaphyseal ends, giving them
a dumb-bell shape. The vertebral bodies are flat and, on
lateral view, have a distinctive pinched appearance, with
a hypoplastic posterior end and a rounded anterior end.
The ribs are typically short and wide and havemetaphyseal
cupping at both ends. The phenotype was named on the
basis of the abnormal morphology of the growth plate,
in which the chondrocytes had a fibroblastic appearance
and there were regions of fibrous cartilage extracellular
matrix.2–5,7,8
The index case reported here was born at term to parents
of Mexican origin. The couple already had five unaffected
children. Although consanguinity was denied, to deter-
mine for counseling purposes whether the phenotype
might be recessive, we performed whole-genome SNP gen-
otyping on a clinical basis. Three large regions of homozy-
gosity were identified: 12.8 Mb at 91,985,291–104,782,487
bp on chromosome 1p21.1-p22.2; 5.5 Mb at 140,785,938–
146,264,218 bp on chromosome 8q24.3; and 15.3 Mb at
17,935,721–33,266,609 bp on chromosome 13q11-q13.2
(NCBI build 36/hg18). These data indicated that the
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inherited and produced by homozygosity for a mutation
in a gene in one of the three intervals. However, after the
initial clinical study, the family declined to participate
further, so additional experiments could not be carried
out in the index case.
The three intervals on chromosomes 1, 8, and 13 con-
tained 389 genes in total. To prioritize these genes for
mutation screening, we hypothesized that the exclusively
skeletal phenotype could be consistent with a mutation in
a gene selectively expressed in cartilage. Gene expression
data for all of the genes was correlated with the expression
patterns of known cartilage-selective genes via the UCLA
Gene Expression Tool (UGET).9 The gene expression data
in UGET are derived from Celsius,10 a large conormalized
microarray dataset of Affymetrix-based gene expression.
In this study, the UGET tool was seeded with the known
cartilage-selective genes,11 C10orf49, COL2A1 (MIM
120140), MATN1 (MIM 115437), LECT1 (MIM 605147),
ACAN (MIM 155760), CSPG4 (MIM 601172), MMP13
(MIM 600108), COL9A3 (MIM 120270), TRPV4 (MIM
605427), and COL11A2 (MIM 120290), and expression
data for the Affymetrix HG-U133 Plus 2 platform were
used for identifying genes that were within the candidate
intervals and whose expression patterns were correlated
with those of the seed genes. The highest correlation was
observed for the gene encoding the a1 chain of collagen
XI (COL11A1; MIM 120280), which was the only known
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Figure 1. Radiographs of Fibrochondrogenesis Case R00-394 at
32 Weeks Gestation
(A) Anterior-posterior view.
(B) Lateral view. Note the short long bones with broad metaphy-
ses, short ribs with metaphyseal cupping, and flat vertebral bodies
with hypoplastic posterior and rounded anterior ends.
Figure 2. Histologic Analysis of Distal Femur Cartilage from
Case R00-394 and Control
(A and B) Light microscopy. Cartilage was decalcified, embedded
in paraffin, and stained with von Kossa trichrome. The fibrochon-
drogenesis case (A, 32 weeks gestation) exhibits fibroblastic chon-
drocytes and a fibrous intercellular matrix not present in the
28-weeks-gestation control (B). Magnification is 403.
(C) Transmission electron microscopy showing frayed and irreg-
ular collagen fibrils.
Table 1. COL11A1 Mutations in Fibrochondrogenesis Cases
Patient ID Exon Nucleotide Change Amino Acid Change
R06-573C 30 c.2386G>C p.Gly796Arg
53 c.3943G>T p.Gly1315X
R00-394 18 c.1786dupG p.Ala596GlyfsX8
42 c.3124G>A p.Gly1042Arg
The nucleotide changes are shown with respect to COL11A1 mRNA sequence
NM_001854.3, and the corresponding predicted amino acid change is
numbered from the initiating methionine residue, where applicable. Exons
are numbered sequentially 1–68, and exons 6 and 7 represent the alternatively
spliced exons 6A and 6B, respectively.Mutation analysis of COL11A1 was carried out commer-
cially (Connective Tissue Gene Tests, Allentown, PA) by
amplification and sequence analysis of all of the 68 coding
exons and splice junction consensus sequences in two
genetically independent cases of fibrochondrogenesis.
The studies were carried out under a protocol approved
by an institutional review board, and informed consent
was obtained from all participants. The proband from
family 1 (International Skeletal Dysplasia Registry refer-
ence number R00-394A) was the first child of parents of
European descent and was stillborn at 32 weeks of gesta-
tion. Subsequently, the couple had two unaffected chil-
dren. The diagnosis was based on the radiographic presen-
tation (Figure 1), cartilage histology demonstrating a
fibroblastic appearance of the chondrocytes (Figure 2A),
and transmission electronmicroscopy of cartilage showing
frayed and irregular collagen fibrils (Figure 2C). Sequence
analysis of COL11A1 (NM_001854.3) revealed compound
heterozygosity for an exon 18 c.1786dupG duplication
that produced a frameshift and subsequent premature
termination codon (p.Ala596GlyfsX8), and an exon 42
c.3124G>A transition that predicts a triple-helical glycine-
to-arginine (p.Gly1042Arg) substitution (Table 1). The
mother had had myopia from about 10 years of age, was
of average stature, had normal hearing, and was heterozy-
gous for the missense mutation. This mutation was absentThe Americanfrom 214 control chromosomes of ethnically matched
individuals. The father reported that he had hearing loss
at age 7 and wore glasses from 6 years of age. He was of
average stature but had experienced joint pain since
childhood. A DNA sample with which to determine
whether he was a carrier for the frameshift mutation was
not available.
To determine whether the c.1786dupG change was
effectively a null mutation or could lead to the production
of a truncated protein, we examined allele-specific expres-
sion based on the c.3124G>A (p.Gly1042Arg) missense
mutation (Figure 3). Total RNA was isolated (RNeasy Mini
Kit, QIAGEN) from P3 cultured chondrocytes derived
from the proband, cDNA was synthesized (High-Capacity
cDNA Reverse Transcription Kit, Applied Biosystems),
and a fragment containing the c.3124G>A (p.Gly1042Arg)
mutation was amplified by PCR. Sequence analysis
revealed that all of the amplified products were derivedJournal of Human Genetics 87, 708–712, November 12, 2010 709
Figure 3. Allele-Specific Expression
Based on the c.3124G>A Missense Muta-
tion in Case R00-394
On the left, the sequence trace of an ampli-
fied genomic DNA fragment containing
the c.3124A missense mutation is shown.
On the right, the sequence trace of an
amplified cDNA fragment containing the
same region is shown, demonstrating the
absence of the c.3124G nucleotide derived
from the c.1786dupG allele.from the missense allele, consistent with nonsense-medi-
ated decay of the transcript derived from the allele with
the insertion mutation.
The proband from family 2 (R06-573C; Figure 4) was the
second affected child born to a father of European descent
and an African-American mother. The pregnancy for the
first affected child was terminated at 24 weeks of gestation
(Figure 4), whereas the second affected child was born at
term. Although the radiographs supported a diagnosis of
fibrochondrogenesis in both affected offspring, the clinical
phenotype of the second child was milder than previously
reported for fibrochondrogenesis, and he is currently alive
at 3 years of age. He has a flat midface, prominent eyes,
short stature, and short limbs, and his hands exhibit
brachyclinodactyly and have some soft-tissue syndactyly
in the web spaces. His trunk is short and narrow, he has
a pectus carinatum, and he breathes without assistance.
He has high myopia and had a left cataract, and there is
mild-to-moderate hearing loss. Sequence analysis of
COL11A1 revealed compound heterozygosity for an exon
30 c.2386G>C change that predicts a glycine-to-arginineFigure 4. Clinical Photograph and Radiographs of Fibrochondroge
(A) The surviving boy (R06-573C) at 19 months of age, presenting wit
shaped thorax.
(B) An anterior-posterior chest radiograph of the boy at 2 months of
(C) A lateral-view radiograph of the spine shows flat vertebral bodies
(D) An anterior-posterior radiograph of the femurs shows short long
(E) Anterior-posterior radiograph of the first affected fetus (R06-573A
710 The American Journal of Human Genetics 87, 708–712, Novemb(p.Gly796Arg) substitution and an exon 53 c.3943G>T
change that predicts a change from a glycine to a premature
termination codon (p.Gly1315X; Table 1). The latter
change was expected to be functionally null, likely via
nonsense-mediated decay of the transcript. Analysis of
DNA from the parents showed that the father was hetero-
zygous for the null mutation and that the mother was
heterozygous for the missense mutation. The missense
mutation was absent from 216 ethnically matched control
chromosomes. The father is of average stature and has
normal vision and mild hearing loss. He reports that his
father and paternal uncle had hearing loss that began in
their 20s and that they required the use of hearing aids.
The mother is of mild short stature for her family and
has normal hearing and mild myopia.
This study demonstrates that mutations in the gene
encoding the a1 chain of type XI procollagen produce
the recessively inherited fibrochondrogenesis phenotype.
Type XI procollagen is a heterotrimeric protein assembled
from the products of three genes, COL11A1, COL11A2
(MIM 120290), and COL2A1 (MIM 120140). Like allnesis Cases from Family R06-573
h a flat midface, small nose with anteverted nares, and a small bell-
age shows short and wide ribs with metaphyseal cupping.
.
bones with broad metaphyses.
) in the family at 24 weeks gestation.
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fibrillar collagens, the structure of the protein is defined by
a long, uninterrupted triple-helical domain specified by
the repeating amino acid sequence Gly-Xaa-Yaa. Glycine
residues at every third position are strictly required for
proper folding of the triple helix, and the helix is stabilized
by hydroxylated proline residues in the Yaa position.
Mature type XI collagen, which accounts for 3%–10% of
the collagenous protein content of cartilage,12,13 forms
heterotypic fibrils with type II collagen, and the ratio
between the molecules appears in part to determine fibril
diameter.14 Molecules composed of different hetero-
combinations of type V and XI collagen chains are also ex-
pressed in a tissue-dependent manner, supporting a role
for the type V/XI collagen polymer as a filamentous
template for type I and II collagen fibrils.15
The fibrochondrogenesis cases studied resulted from
compound heterozygosity for two types of COL11A1
mutations that imply two mechanisms that together
contribute to development of the disease. First, the null
allele predicts reduced synthesis of the proa1(XI) chain.
Although this might predict reduced synthesis of type XI
procollagen, in mice heterozygous for the chondrodyspla-
sia (cho/þ)Col11a1 null mutation,16 there is some incorpo-
ration of proa1(V) chains into type XI procollagen
molecules, and this partially compensates for the reduced
synthesis of the proa1(XI) chain.14 Second, mutant
proa1(XI) chains, encoded by the allele with the mutation
leading to the glycine substitution, would be expected to
disrupt the triple-helical structure of molecules into which
they were incorporated. Thus, the combined effects of
these two mechanisms could lead to the disruption of
the structure of the type II/type XI collagen heterotypic
fibril observed in fibrochondrogenesis. However, it was
not possible to define the consequences of the mutations
on type XI collagen synthesis because cartilage for bio-
chemical analysis was not available for these two cases.
Mutations in COL11A1 have previously been reported to
cause autosomal-dominant forms of Stickler (MIM 604841)
and Marshall (MIM 154780) syndromes, which are charac-
terized by mild facial dysmorphism, sensorineural hearing
loss, and myopia.17–21 In eight of the reported cases, the
phenotype results from heterozygosity for mutations
leading to glycine substitutions in the proa1(XI) chain.
These data suggest that the phenotypic abnormalities in
the fibrochondrogenesis carrier parents, who were not
identified as having Stickler/Marshall syndrome, could
result from their mutant COL11A1 alleles. For the null
alleles, hearing loss appears to be the major manifestation,
suggesting COL11A1 as a locus for mild, early-onset
hearing loss. Mutations in the paralogous type XI procolla-
gen gene, COL11A2, are known to produce both auto-
somal-dominant and recessive forms of hearing loss.22,23
For the glycine substitutions, the parental phenotypes
included mild short stature and myopia. However, it will
be necessary to study additional carriers to determine
how consistent the observed pattern is, as well as to docu-
ment in detail the extent of phenotypic abnormalitiesThe Americanobserved in the hearing and vision of carriers. Further-
more, for glycine substitutions in fibrillar collagen mole-
cules, phenotypic consequences are known to vary with
the specific amino acid and substituting residue involved,
as most extensively documented for osteogenesis imper-
fecta.24 It will therefore be important to study additional
cases to develop a clearer understanding of the range of
expression of the carrier phenotype among parents and
unaffected siblings of fibrochondrogenesis cases.
The chondrodysplasia (cho/cho) mouse,16 which results
from homozygosity for a functional null allele of Col11a1,
might represent an appropriate animal model for fibro-
chondrogenesis. Homozygousmutant animals have a short
snout, their long bones and ribs are short, wide, and have
flared metaphyses, their spine is short with irregular verte-
brae, and their thoracic cage is small, likely explaining the
neonatal lethality of the phenotype.25 At the ultrastruc-
tural level, collagen fibrils in the cartilage extracellular
matrix are sparsely distributed and abnormally thick, and
they display a repeating transverse banding pattern14,25
not unlike that seen in fibrochondrogenesis. Thus, it is
possible that, in addition to the mechanisms described
here, absence of the COL11A1 gene product could also
produce fibrochondrogenesis.
Fibrochondrogenesis thus defines the most severe end of
a spectrum of disorders involving the type XI procollagen
genes characterized to date. Especially given the nonlethal
case described here, which bears some similarity to a case
of recessive spondyloepimetaphyseal dysplasia,26 we
suspect that additional mutations in COL11A1 will be
found to cause dominant or recessive disorders of interme-
diate severity between fibrochondrogenesis and Stickler/
Marshall syndrome. Identification of mutations in fibro-
chondrogenesis will facilitate diagnostic testing for fami-
lies and, for the carrier parents, siblings, and other family
members, early surveillance for abnormalities in vision
and hearing.Acknowledgments
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